Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis-Reference-Cited by-同舟云学术

Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis

Published:2021-04-26 Issue:8 Volume:70 Page:1767-1779
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

Albiero Mattia,Tedesco Serena,Amendolagine Francesco Ivan,D’Anna Marianna,Migliozzi Ludovica,Zuccolotto Gaia,Rosato Antonio,Cappellari Roberta,Avogaro Angelo,Fadini Gian Paolo^ORCID

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference44 articles.

1. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

2. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

3. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

4. Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review;Lopaschuk;JACC Basic Transl Sci,2020

5. Are the favorable cardiovascular outcomes of empagliflozin treatment explained by its effects on multiple cardiometabolic risk factors? A simulation of the results of the EMPA-REG OUTCOME trial;Kuo;Diabetes Res Clin Pract,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial;Med;2024-07

2. Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond;Basic Research in Cardiology;2024-06-27

3. Potential of dapagliflozin to prevent vascular remodeling in the rat carotid artery following balloon injury;Atherosclerosis;2024-05

4. Progenitor Cell Function and Cardiovascular Remodelling Induced by SGLT2 Inhibitors;Frontiers in Bioscience-Landmark;2024-04-09

5. Empagliflozin attenuates radiation-induced hematopoietic damage via NOX-4/ROS/p38 pathway;Life Sciences;2024-03